Marvin Edeas - Microbiota
Marvin Edeas (https://www.microbiota-site.com/microbiota-medicine-of-tomorrow-by-marvin-edeas-chairman-of-ism-scientific-committee.html) carries out clinical studies in nephrology patients and studies the impact of microbiota metabolites on mitochondrial activity of such patients. The research he undertakes concentrates on the effects of Inflammation and Oxidative Stress in chronic diseases. Marvin Edeas frequently works with INSERM, Paris Descartes University and CNRS in the Department responsible for Development, Reproduction and Cancer (DRC).
Marvin Edeas, ISANH and the SFA work to transfer their research to real applications whether clinical, pharmaceutical, nutritional or cosmetic. As well as being dedicated to their benefits in preventative and therapeutic medicine, the SFA promotes the use of antioxidants in nutrition and health. Research on mitochondria, microbiota, oxidative stress, inflammation, differentiation, cell signalling, Nrf2 transcription factors stimulation and their significance in various pathologies are the main focus of Marvin Edeas’ research. The relationship between mitochondria and microbiota is his foremost focus.
Marvin Edeas - Important Research on HIV
The six years he spent at Antoine Béclère Hospital made it possible for him to investigate the latency mechanisms of the HIV virus in patients suffering HIV, in addition to the activation factors. Marvin Edeas was a participant in the very first clinical study which looked at the impact of antiretroviral therapy on hyperlactatemia and lactic acidosis. Marvin Edeas was recognised by Sidaction for his work on HIV.
The Background of Marvin Edeas
Marvin Edeas educated at the Paris 13 Bobigny and Poitiers Universities between the years 2004 and 2013. Marvin Edeas acquired his doctorate on HIV infections in asymptomatic patients from Antoine Béclère Hospital in the year 1998. He focused on gastrointestinal diseases in Pitié Salpêtrière’s Department of Internal Medicine.